Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1995; Volume 48,Issue 1
  • You have access
    Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
    Y Chern, J Y Chiou, H L Lai and M H Tsai
    Molecular Pharmacology July 1995, 48 (1) 1-8;
  • You have access
    Studies on neuropeptide Y receptors in a mouse adrenocortical cell line.
    G Weng, F Yee, P Michl, D Reis and C Wahlestedt
    Molecular Pharmacology July 1995, 48 (1) 9-14;
  • You have access
    Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.
    H J Prochaska, W G Bornmann, P Baron and B Polsky
    Molecular Pharmacology July 1995, 48 (1) 15-20;
  • You have access
    B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
    C Borchers, W R Ulrich, K Klemm, W Ise, V Gekeler, S Haas, A Schödl, J Conrad, M Przybylski and R Boer
    Molecular Pharmacology July 1995, 48 (1) 21-29;
  • You have access
    Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.
    P De Isabella, M Palumbo, C Sissi, G Capranico, N Carenini, E Menta, A Oliva, S Spinelli, A P Krapcho and F C Giuliani
    Molecular Pharmacology July 1995, 48 (1) 30-38;
  • You have access
    Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.
    C C Chen, J Chang and W C Chen
    Molecular Pharmacology July 1995, 48 (1) 39-47;
  • You have access
    Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.
    R E Link, M S Stevens, M Kulatunga, M Scheinin, G S Barsh and B K Kobilka
    Molecular Pharmacology July 1995, 48 (1) 48-55;
  • You have access
    Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
    S Cavallaro, V D'Agata, V Guardabasso, S Travali, F Stivala and P L Canonico
    Molecular Pharmacology July 1995, 48 (1) 56-62;
  • You have access
    Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    J F Margiotta and D Pardi
    Molecular Pharmacology July 1995, 48 (1) 63-71;
  • You have access
    Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
    R T Reilly, K W Barbour, R B Dunlap and F G Berger
    Molecular Pharmacology July 1995, 48 (1) 72-79;
  • You have access
    Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide.
    P A Glascott, E Gilfor and J L Farber
    Molecular Pharmacology July 1995, 48 (1) 80-88;
  • You have access
    Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line.
    B Rehberg, E Bennett, Y H Xiao, S R Levinson and D S Duch
    Molecular Pharmacology July 1995, 48 (1) 89-97;
  • You have access
    WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
    R J Hill, A M Grant, W Volberg, L Rapp, C Faltynek, D Miller, K Pagani, E Baizman, S Wang and J W Guiles
    Molecular Pharmacology July 1995, 48 (1) 98-104;
  • You have access
    alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
    D R Groebe, J M Dumm, E S Levitan and S N Abramson
    Molecular Pharmacology July 1995, 48 (1) 105-111;
  • You have access
    Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
    L M Winn and P G Wells
    Molecular Pharmacology July 1995, 48 (1) 112-120;
  • You have access
    Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
    P F Méry, C Pavoine, F Pecker and R Fischmeister
    Molecular Pharmacology July 1995, 48 (1) 121-130;
  • You have access
    Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons.
    T M Piser, R A Lampe, R A Keith and S A Thayer
    Molecular Pharmacology July 1995, 48 (1) 131-139;
  • You have access
    Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.
    P A Johansen, L A Chase, A D Sinor, J F Koerner, R L Johnson and M B Robinson
    Molecular Pharmacology July 1995, 48 (1) 140-149;
  • You have access
    Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    J Labrecque, A Fargin, M Bouvier, P Chidiac and M Dennis
    Molecular Pharmacology July 1995, 48 (1) 150-159;
  • You have access
    Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.
    J A Yao, N C Saxena, M R Ziai, S Ling and G N Tseng
    Molecular Pharmacology July 1995, 48 (1) 160-171;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 48, Issue 1
1 Jul 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics